Evidence map›Paper›PMID 41282305›Full record

ArticleAmerican heart journal plus : cardiology research and practice2025

Rene Labounek, Matti J Matheson, Ashley J Petersen, Adam Hansen, Adam D Block, Corey Strong, Annamarie Hill, Meghan Kremer, Ann J Robertson, Valmiki Maharaj and 6 more

Abstract read
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rene LabounekDivision of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN, 55414, United States of America.
Matti J MathesonDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Ashley J PetersenDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Adam HansenDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Adam D BlockDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Corey StrongBois Forte Band of Chippewa, Health Services, Nett Lake, MN, 55771, United States of America.
Annamarie HillDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Meghan KremerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Ann J RobertsonDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Valmiki MaharajDepartment of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Kamakshi LakshminaryanDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
Danni LiDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, 55455, United States of America.
J Neil HendersonDepartment of Family Medicine and Biobehavioral Health, University of Minnesota Duluth, Duluth, MN, 55805, United States of America.
Igor NestrasilDivision of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN, 55414, United States of America.
Christophe LengletCenter for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN, 55455, United States of America.
William G MantyhDepartment of Neurology, University of Minnesota, Minneapolis, MN, 55455, United States of America.

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8M
Dementia prevalence, APOE, and blood-based biomarkers of AD in Native American communitiesR01AG080806 · NIA · UNIVERSITY OF MINNESOTA · PI William G Mantyh · 2022 to 2026
$3.7M
NCATS NIH HHS UM1 TR004405NIA NIH HHS R01 AG080806
6 · The paper itself

Abstract

Objective: American Indian/Indigenous (AI) populations have the highest rate of ischemic heart disease (IHD) of any racial or ethnic group in the United States. While modifiable cardiovascular risk factors represent a well-established source of elevated IHD in AI, little is known regarding genetic IHD influences, in particular Methods: We performed a cross-sectional, community-based study including tribal Elders (ages >54 years) at the Bois Forte Band of Chippewa in the state of Minnesota. We collected data pertaining to demographics, cardiovascular risk factors, Findings: One-hundred-eighty-one participants were included. Their median age and interquartile range were 67 (61, 73) years, AI ancestry was 75 % (50 %, 100 %), 126 (70 %) were females, 46 (25 %) were Conclusions:

Indexed as

American IndianAPOE ε4HyperlipidemiaHypertensionIndigenousIschemic heart disease

Identifiers

PMID41282305
PMCPMC12639555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.